Literature DB >> 14625851

Proteomic analysis of mdx skeletal muscle: Great reduction of adenylate kinase 1 expression and enzymatic activity.

Yue Ge1, Mark P Molloy, Jeffrey S Chamberlain, Philip C Andrews.   

Abstract

To investigate the pathophysiological events of Duchenne muscular dystrophy, we analyzed alterations of protein expression in hindlimb muscles of three month old mdx mice using two-dimensional gel electrophoresis and mass spectrometry. About 40 differentially expressed proteins from the cytosolic fraction and 20 from the microsomal fraction of mdx hindlimb muscles were identified. Among these altered proteins, adenylate kinase 1 (AK 1) was particular interesting because its decrease in abundance was so dramatic (> four-fold). Enzymatic assays demonstrated that AK 1 activity was also decreased in mdx mice. Furthermore, the expression and enzymatic activity of AK 1 were consistently reduced in mdx mice at one and six months of age, suggesting a direct relationship between the lack of dystrophin and alteration of AK 1. Along with AK 1, creatine kinase (CK) provides a major pathway for regulation of nucleotide ratios and energy metabolism in muscles. To gain a better understanding of mechanisms of energy metabolism, we also investigated CK activities in these mdx mice at different ages. Our results suggested that decreased AK 1 expression and activity might result in redistribution of energy flow through the alternative CK system, thus a compensatory potential might limit cellular energy failure in mdx skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625851     DOI: 10.1002/pmic.200300561

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  28 in total

Review 1.  Proteomic profiling of x-linked muscular dystrophy.

Authors:  Caroline Lewis; Steven Carberry; Kay Ohlendieck
Journal:  J Muscle Res Cell Motil       Date:  2009-12       Impact factor: 2.698

2.  Identification of disease specific pathways using in vivo SILAC proteomics in dystrophin deficient mdx mouse.

Authors:  Sree Rayavarapu; William Coley; Erdinc Cakir; Vanessa Jahnke; Shin'ichi Takeda; Yoshitsugu Aoki; Heather Grodish-Dressman; Jyoti K Jaiswal; Eric P Hoffman; Kristy J Brown; Yetrib Hathout; Kanneboyina Nagaraju
Journal:  Mol Cell Proteomics       Date:  2013-01-07       Impact factor: 5.911

3.  Dystrophinopathy-associated dysfunction of Krebs cycle metabolism.

Authors:  Angus Lindsay; Christopher M Chamberlain; Bruce A Witthuhn; Dawn A Lowe; James M Ervasti
Journal:  Hum Mol Genet       Date:  2019-03-15       Impact factor: 6.150

4.  The effect of respiratory muscle training with CO2 breathing on cellular adaptation of mdx mouse diaphragm.

Authors:  Stefan Matecki; François Rivier; Gerald Hugon; Christelle Koechlin; Alain Michel; Christian Prefaut; Dominique Mornet; Michele Ramonatxo
Journal:  Neuromuscul Disord       Date:  2005-04-18       Impact factor: 4.296

Review 5.  Adenylate kinase and AMP signaling networks: metabolic monitoring, signal communication and body energy sensing.

Authors:  Petras Dzeja; Andre Terzic
Journal:  Int J Mol Sci       Date:  2009-04-17       Impact factor: 6.208

6.  Proteomic Profiling of the Dystrophin-Deficient MDX Heart Reveals Drastically Altered Levels of Key Metabolic and Contractile Proteins.

Authors:  Caroline Lewis; Harald Jockusch; Kay Ohlendieck
Journal:  J Biomed Biotechnol       Date:  2010-05-23

7.  Quantitative proteomic analysis reveals metabolic alterations, calcium dysregulation, and increased expression of extracellular matrix proteins in laminin α2 chain-deficient muscle.

Authors:  Bruno Menezes de Oliveira; Cintia Y Matsumura; Cibely C Fontes-Oliveira; Kinga I Gawlik; Helena Acosta; Patrik Wernhoff; Madeleine Durbeej
Journal:  Mol Cell Proteomics       Date:  2014-07-03       Impact factor: 5.911

8.  Reduced IGF signaling prevents muscle cell death in a Caenorhabditis elegans model of muscular dystrophy.

Authors:  Kelly Hyunju Oh; Hongkyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-04       Impact factor: 11.205

Review 9.  Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy.

Authors:  Miranda D Grounds; Hannah G Radley; Gordon S Lynch; Kanneboyina Nagaraju; Annamaria De Luca
Journal:  Neurobiol Dis       Date:  2008-04-09       Impact factor: 5.996

10.  Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic mdx diaphragm.

Authors:  Philip Doran; Steve D Wilton; Sue Fletcher; Kay Ohlendieck
Journal:  Proteomics       Date:  2009-02       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.